Comparison of Trial-Collected and Parent-Reported Race and Ethnicity in a Children’s Oncology Group Trial Introduction Children with cancer who are Black or Hispanic are more likely to experience cancer recurrence and die, despite standardized treatment on National Clinical Trials Network (NCTN) Children’s Oncology Group (COG) trials.1 Accurate race and ethnicity data are essential to characterizing these disparities and designing effective interventions.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile